Ginger
CAS 84696-15-1
Ginger (CAS 84696-15-1) is a pharmaceutical compound with 0 bioactivity targets and 344 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Label Active Ingredients
Active ingredient and active moiety rows from source drug product labels.
| Product | Ingredient | Active Moiety | Effective |
|---|---|---|---|
| Heartburn | GINGER C5529G5JPQ |
GINGER | 20260505 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| GINGER | 899420 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ginger used for in pharmaceutical contexts?
Ginger (CAS 84696-15-1) appears in DailyMed active-ingredient label rows, including Heartburn.
What are the known adverse events for Ginger?
Ginger has 344 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal pain, Abdominal pain upper, Accidental exposure to product. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ginger also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Zingiber Officinale Root Extract with EU status "permitted".
What clinical phase is Ginger in?
No phase 1-4 clinical development badge is rendered for Ginger because the matched compound identifier rows do not contain a max-phase value.